SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,692.16 809.34
(1.66%)

Dow Jones

7,235.98 79.03
(1.10%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,371.76 158.65
(1.55%)

Forex

USD-INR

94.79 0.27
(0.29%)

EUR-INR

110.85 0.20
(0.18%)

GBP-INR

127.93 0.23
(0.18%)

JPY-INR

0.59 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

24.267589

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

82.86

3963.61

EPS(TTM)

Face Value()

Div & Yield %

4.39

0.18

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	150.80	169.82	148.39	114.85	90.56	85.12
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	150.80	169.82	148.39	114.85	90.56	85.12
Other Income	1.68	4.38	6.59	4.05	3.27	1.70
Stock Adjustments	1.27	-11.01	3.24	5.13	0.38	4.11
Total Income	153.75	163.19	158.22	124.03	94.21	90.93
EXPENDITURE :
Raw Materials	25.78	25.67	29.73	21.75	15.75	15.44
Power & Fuel Cost	26.63	26.53	26.41	21.73	16.57	22.86
Employee Cost	11.44	10.21	7.75	7.08	7.11	6.43
Other Manufacturing Expenses	8.44	6.79	6.80	7.91	8.79	10.53
Selling & Administrative Expenses	5.81	8.59	6.66	2.31	1.86	1.64
Miscellaneous Expenses	4.36	2.29	0.64	1.15	0.53	0.49
Less : Pre-operative Expenses Capitalised	-0.01	-0.01	0.00	0.00	0.00	0.00
Total Expenditure	82.48	80.09	77.99	61.94	50.61	57.39
Operating Profit	71.27	83.10	80.22	62.10	43.59	33.54
Interest	0.36	0.23	0.18	0.83	0.98	0.92
Gross Profit	70.91	82.87	80.04	61.27	42.61	32.62
Depreciation	5.37	3.54	2.58	2.23	1.73	1.36
Profit Before Tax	65.54	79.33	77.46	59.04	40.88	31.26
Tax	16.49	19.80	19.24	15.34	10.58	7.64
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.28	0.38	0.26	0.07	0.13	-0.05
Reported Net Profit	48.77	59.16	57.97	43.62	30.18	23.67
Extraordinary Items	0.00	0.00	0.00	0.00	0.01	0.62
Adjusted Net Profit	48.77	59.16	57.97	43.62	30.17	23.05
Adjustment below Net Profit	-1.42	-0.03	0.06	-0.08	-0.03	0.00
P & L Balance brought forward	191.79	139.56	93.74	60.36	32.61	8.93
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.82	6.90	12.20	10.17	2.40	0.00
P & L Balance carried down	237.33	191.79	139.56	93.74	60.36	32.61
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	67.00	100.00	108.00	220.00	0.00	33.00
Dividend Per Share(Rs)	0.67	1.00	5.40	11.00	0.00	1.65
Earnings Per Share-Unit Curr	4.48	8.14	39.90	30.03	20.77	16.30
Earnings Per Share(Adj)-Unit Curr	4.48	5.43	5.32	4.00	2.77	2.17
Book Value-Unit Curr	22.79	27.72	102.66	71.11	48.14	29.04
Book Value(Adj)-Unit Curr	22.79	18.48	13.69	9.48	6.42	3.87

76,913.50 -582.86 ( -0.75%)

49,692.16 809.34 (1.66%)

7,235.98 79.03 (1.10%)

59,594.47 309.55 (0.52%)

10,371.76 158.65 (1.55%)

94.79 0.27 (0.29%)

110.85 0.20 (0.18%)

127.93 0.23 (0.18%)

0.59 0.00 (-0.01%)